Ronald J Daniels is Director of BridgeBio Pharma, Inc.. Currently has a direct ownership of 16,991 shares of BBIO, which is worth approximately $1.13 Million. The most recent transaction as insider was on Nov 06, 2025, when has been sold 61,031 shares (Common Stock) at a price of $63.72 per share, resulting in proceeds of $3,888,895. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17K
0% 3M change
63.34% 12M change
Total Value Held $1.13 Million

RONALD J DANIELS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 06 2025
SELL
Open market or private sale
$3,888,895 $63.72 p/Share
61,031 Reduced 78.22%
16,991 Common Stock
Nov 06 2025
BUY
Exercise of conversion of derivative security
$2,114,724 $34.65 p/Share
61,031 Added 43.89%
78,022 Common Stock
Jun 20 2025
BUY
Grant, award, or other acquisition
-
6,589 Added 27.94%
16,991 Common Stock
Dec 30 2021
BUY
Open market or private purchase
$149,165 $14.34 p/Share
10,402 Added 50.0%
10,402 Common Stock
Dec 28 2021
SELL
Open market or private sale
$150,336 $12.8 p/Share
11,745 Reduced 100.0%
0 Common Stock
Dec 28 2021
BUY
Open market or private purchase
$149,514 $12.73 p/Share
11,745 Added 50.0%
11,745 Common Stock
RJD

Ronald J Daniels

Director
Palo Alto, CA

Track Institutional and Insider Activities on BBIO

Follow BridgeBio Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

News

Receive news related to BridgeBio Pharma, Inc.

Track Activities on BBIO